top of page

The Inflation Reduction Act Will Lead to Fewer New Medicines

The impact of the Inflation Reduction Act on the biopharmaceutical industry is going to be substantial in a number of ways. Already companies are analyzing the strategies...



We Work For Health brings together national and local business leaders, labor, biopharma, patient advocacy, and other healthcare-related stakeholders to support policies and initiatives that foster innovation and facilitate the delivery of lifesaving and life-enhancing medicines. 

We Work For Health. © 2023 All Rights Reserved.

bottom of page